HF
NRXP icon

HRT Financial’s NRX Pharmaceuticals NRXP Stock Holding History

HRT Financial’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,650
Closed -$29K – 2965
2022
Q4 		$29K Buy
+2,650
New +$26.7K ﹤0.01% 2148
2021
Q1 		– Sell
-1,181
Closed -$288K – 3007
2020
Q4 		$288K Buy
+1,181
New +$194K 0.01% 1311

Other funds holding NRXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

HRT Financial's NRXP Position: Q1 2023 in Review

HRT Financial sold out of NRX Pharmaceuticals (NRXP) in Q1 2023, closing a stake of 2,650 shares — an estimated $29K sold.

HRT Financial first reported a position in NRXP in Q4 2020 and held it in 2 quarters. The position peaked at $288K in Q4 2020. 30 funds tracked by Wall St. Rank hold NRXP as of Q1 2023.

  • HRT Financial reported no remaining NRX Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 2,650 NRX Pharmaceuticals shares in Q1 2023, an estimated $29K.
  • HRT Financial first reported a position in NRX Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • HRT Financial's NRX Pharmaceuticals position peaked at $288K in Q4 2020.
  • 30 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.